The association between use of a clinical decision support tool and adherence to monitoring for medication- laboratory guidelines in the ambulatory setting

Applied Clinical Informatics

Volumn 4, Issue 4, 2013, Pages 476-498

  Lau, B ^a   Overby, C L ^a,c   Wirtz, H S ^a   Devine, E B ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

Author keywords

Adherence to guidelines; Clinical decision support; Clinical guidelines; Meaningful use; Medication laboratory test monitoring

Indexed keywords

ANTIDIABETIC AGENT; ANTILIPEMIC AGENT;

ADHERENCE TO GUIDELINES; AMBULATORY CARE; ARTICLE; CLINICAL DECISION SUPPORT; CLINICAL GUIDELINES; DECISION SUPPORT SYSTEM; DIABETES MELLITUS; FEMALE; HUMAN; LABORATORY; MALE; MEANINGFUL USE CRITERIA; MEDICATION LABORATORY TEST MONITORING; MIDDLE AGED; PRACTICE GUIDELINE; PRESCRIPTION; REGISTER; SAFETY; STATISTICS; UTILIZATION REVIEW;

ADHERENCE TO GUIDELINES; CLINICAL DECISION SUPPORT; CLINICAL GUIDELINES; MEANINGFUL USE; MEDICATION LABORATORY TEST MONITORING;

AMBULATORY CARE; DECISION SUPPORT SYSTEMS, CLINICAL; DIABETES MELLITUS; DRUG PRESCRIPTIONS; FEMALE; GUIDELINE ADHERENCE; HUMANS; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; LABORATORIES; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; REGISTRIES; SAFETY;

EID: 84886046481     PISSN: None     EISSN: 18690327     Source Type: Journal    
DOI: 10.4338/ACI-2013-06-RA-0041     Document Type: Article

References (30)

1. American Reinvestment and Recovery Act of 2009, Public Law III-5. [accessed on September 28, 2013]. Available at: http://www.gpo.gov/fdsys/pkg/PLAW-111publ5/pdf/PLAW-111publ5.pdf
2. Centers for Medicare and Medicaid Services. 2012. Meaningful Use. [accessed on September 28, 2013]. Available at: http://www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/Mean ingful_Use.html
3. Centers for Medicare and Medicaid Services. 2012. Stage 2. [accessed on September 28, 2013]. Available at: http://www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/Stage_2.html
4. Centers for Medicare and Medicaid Services. 2012. Stage 1 versus Stage 2 comparison table for eligible professionals. Last updated: August 2012. [accessed on September 28, 2013]. Available at: http://www.cms. gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/Downloads/Stage1vsStage2CompTablesforEP. pdf
5. Lobach D, et al. April 2012. Enabling Health Care Decision making Through Clinical Decision Support and Knowledge Management. Evidence Report No. 203. (Prepared by the Duke Evidence-based Practice Center under Contract No. 290-2007-10066-I.) AHRQ Publication No. 12-E001-EF. Rockville, MD: Agency for Healthcare Research and Quality
6. Romano MJ, Stafford RS. Electronic health records and clinical decision support systems: Impact on national ambulatory care quality. Archives of Internal Medicine 2011; 171(10): 897-903. [PubMed: 21263077]
7. Walsh MN, et al. Lack of association between electronic health record systems and improvement in use of evidence-based heart failure therapies in outpatient cardiology practices. Clinical Cardiology 2012; 35(3): 187-196. [PubMed: 22328100]
8. Wright A, et al. Clinical decision support capabilities of commercially-available clinical information systems. Journal of the American Medical Informatics Association 2009; 16(5): 637-644. [PubMed: 19567796]
9. Chaffee BW. Future of clinical decision support in computerized prescriber order entry. American Journal of Health-System Pharmacy 2010; 67(11): 932-935. [PubMed: 20484218]
10. Eberhardt J, Bilchik A, Stojadinovic A. Clinical decision support: potential with pitfalls. Journal of Surgical Oncology 2012; 105(5): 502-510. [PubMed: 22441903]
11. Sittig DF, Wright A, Osheroff JA. Grand challenges in clinical decision support. Journal of Biomedical Informatics 2008; 41(2): 387-392. [PubMed: 18029232]
12. Moxey A, et al. Computerized clinical decision support for prescribing: provision does not guarantee update. Journal of the American Medical Informatics Association 2010; 17(1): 25-33. [PubMed: 20064798]
13. Cash JJ. Alert fatigue. American Journal of Health-System Pharmacy 2009; 66(23): 2098-20101. [PubMed: 19923309]
14. Anderegg SV, Gumpper KF. What meaningful use means for pharmacy. American Journal of Health-System Pharmacy 2012; 69(10): 890-894. [PubMed: 22555086]
15. Garg AX, et al. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes. A systematic review. JAMA 2005; 293(10): 1223-1228. [PubMed: 15755945]
16. Das M, Eichner J. March 2010. Challenges and barriers to clinical decision support (CDS) design and implementation experienced in the Agency for Healthcare Research and Quality CDS Demonstrations. (Prepared for the AHRQ National Resource Center for Health Information Technology under Contract No. 290-04-0016.) AHRQ Publication No. 10-0064-EF. Rockville, MD: Agency for Healthcare Research and Quality.
17. Devine EB, et al. The impact of computerized provider order entry on medication errors in a multispecialty group practice. Journal of the American Medical Informatics Association 2010; 17(1): 78-84. [PubMed: 20064806]
18. EPICare's Ambulatory EMR® (Verona, WI) [accessed on September 28, 2013] Available at: http://www. epic.com/software-ambulatory.php
19. Devine EB, et al. August 2008. Implementing an ambulatory e-prescribing system: strategies employed and lessons learned to minimize unintended consequences. In: Henriksen K, Battles JB, Keyes MA, Grady ML, editors. Advances in Patient Safety: New Directions and Alternative Approaches (Vol. 4: Technology and Medication Safety). Rockville (MD): Agency for Healthcare Research and Quality.
20. Standards of Medical Care in Diabetes-2008 (Executive Summary). Diabetes Care 2008; 31(Suppl. 1): S5-S11.
21. Standards of Medical Care in Diabetes-2008 (Executive Summary). Diabetes Care 2009; 32(Suppl. 1): S6-S12
22. Third Report of the National Cholesterol Education Program on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). (Executive Summary). May 2001. National Cholesterol Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health. NIH Publication No. 01-3670.
23. Liang KY, Zeger SL. Longitudinal Data Analysis Using Generalized Linear Models. Biometrika 1986; 73(1): 13-22.
24. Smith DH, et al. The impact of prescribing safety alerts for elderly persons in an electronic medical record. Archives of Internal Medicine 2006; 166(10): 1098-1104. [PubMed: 16717172]
25. Lo HG, et al. Impact of non-interruptive medication laboratory monitoring alerts in ambulatory care. Journal of the American Medical Informatics Association 2009; 16(1): 66-71. [PubMed: 18952945]
26. Singh H, et al. Modification of abnormal lab test results in an electronic medical record: do any safety concerns remain? American Journal of Medicine 2010; 123(3): 238-244. [PubMed: 20193832]
27. Agrawal A, Mayo-Smith MF. Adherence to computerized clinical reminders in a large healthcare delivery network. Studies in Health Technology Informatics 2004; 107(Pt 1): 111-114. [PubMed: 15360785]
28. Bundy DG, et al. Electronic health record-based monitoring of primary care patients at risk of medication-related toxicity. Jt Comm J Qual Patient Saf 2012; 38(5): 216-223. [PubMed: 22649861]
29. Fischer SH, Tjia J, Field TS. Impact of health information technology interventions to improve medication laboratory monitoring for ambulatory patients: a systematic review. Journal of the American Medical Informatics Association 2010; 17: 631-636. [PubMed: 20962124]
30. Cowansage CB, et al. An application for monitoring order set usage in a commercial electronic health record. AMIA Annu Symp Proc 2012: 1184-1190. [PubMed: 23304395]